Doxacurium chloride: Difference between revisions

Doxacurium chloride
	File:Doxacurium chloride.svg
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Latest revision as of 06:24, 16 February 2025

A non-depolarizing neuromuscular blocking agent

Doxacurium chloride is a non-depolarizing neuromuscular blocking agent used in anesthesia to induce muscle relaxation during surgery or mechanical ventilation. It is a member of the benzylisoquinolinium class of neuromuscular blockers.

Mechanism of Action[edit]

Doxacurium chloride works by competitively inhibiting the action of acetylcholine at the neuromuscular junction. It binds to the nicotinic acetylcholine receptor on the motor end plate, preventing acetylcholine from binding and thus blocking the transmission of nerve impulses to the muscle.

Pharmacokinetics[edit]

Doxacurium chloride is administered intravenously. It has a slow onset and a long duration of action compared to other neuromuscular blockers. The drug is metabolized in the liver and excreted primarily in the urine.

Clinical Use[edit]

Doxacurium chloride is used to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is particularly useful in procedures that require prolonged muscle relaxation.

Side Effects[edit]

Common side effects of doxacurium chloride include hypotension, flushing, and bronchospasm. As with other neuromuscular blockers, there is a risk of prolonged paralysis and respiratory depression if not properly monitored.

Contraindications[edit]

Doxacurium chloride should not be used in patients with known hypersensitivity to the drug or any of its components. Caution is advised in patients with myasthenia gravis or other neuromuscular disorders.

Related pages[edit]

@@ Line 1: / Line 1: @@
-'''Doxacurium chloride''' is a long-acting [[neuromuscular-blocking drug]] (NMBD) used primarily in anesthesia to facilitate [[endotracheal intubation]] and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is a bisquaternary benzylisoquinolinium compound with no significant intrinsic [[ganglion-blocking]] properties. Doxacurium chloride operates by competing with [[acetylcholine]] for the nicotinic receptors at the motor end plate, inducing skeletal muscle paralysis.
+{{Short description|A non-depolarizing neuromuscular blocking agent}}
+{{Drugbox
+| verifiedfields = changed
+| verifiedrevid = 477002123
+| image = Doxacurium_chloride.svg
+| image2 = <!-- Another image if available -->
+| width = 200px
+| alt =
+| caption = Chemical structure of Doxacurium chloride
+}}
-==Pharmacology==
+'''Doxacurium chloride''' is a [[non-depolarizing neuromuscular blocking agent]] used in [[anesthesia]] to induce [[muscle relaxation]] during [[surgery]] or [[mechanical ventilation]]. It is a member of the [[benzylisoquinolinium]] class of neuromuscular blockers.
-Doxacurium chloride is known for its lack of significant cardiovascular effects, making it suitable for patients with cardiovascular diseases. It does not release [[histamine]], minimizing the risk of hypotension and flushing. The onset of action is relatively slow compared to other neuromuscular blockers, and its duration of action is long, which makes it particularly useful for procedures requiring extended periods of muscle relaxation.
-===Mechanism of Action===
+==Mechanism of Action==
-Doxacurium chloride acts by binding competitively to the nicotinic acetylcholine receptors at the neuromuscular junction. This binding inhibits the action of acetylcholine, a neurotransmitter responsible for the initiation of muscle contractions, thereby causing paralysis of the skeletal muscles.
+Doxacurium chloride works by competitively inhibiting the action of [[acetylcholine]] at the [[neuromuscular junction]]. It binds to the [[nicotinic acetylcholine receptor]] on the [[motor end plate]], preventing acetylcholine from binding and thus blocking the transmission of nerve impulses to the muscle.
-===Pharmacokinetics===
+==Pharmacokinetics==
-The pharmacokinetics of doxacurium chloride are characterized by a slow onset and a long duration of action. It is primarily eliminated by the kidneys, and to a lesser extent, by the liver. The elimination half-life is prolonged in patients with renal and hepatic impairment, necessitating dosage adjustments in these populations.
+Doxacurium chloride is administered intravenously. It has a slow onset and a long duration of action compared to other neuromuscular blockers. The drug is metabolized in the [[liver]] and excreted primarily in the [[urine]].
 ==Clinical Use==
-Doxacurium chloride is used in the operating room setting for procedures that require a deep level of muscle relaxation for an extended period. It is also used in critical care settings for facilitating mechanical ventilation in patients who require long-term ventilatory support.
+Doxacurium chloride is used to facilitate [[endotracheal intubation]] and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is particularly useful in procedures that require prolonged muscle relaxation.
-===Indications===
+==Side Effects==
-* Facilitation of [[endotracheal intubation]]
+Common side effects of doxacurium chloride include [[hypotension]], [[flushing]], and [[bronchospasm]]. As with other neuromuscular blockers, there is a risk of [[prolonged paralysis]] and [[respiratory depression]] if not properly monitored.
-* Provision of skeletal muscle relaxation during surgery
-* Facilitation of mechanical ventilation in ICU settings
-===Contraindications===
+==Contraindications==
-* Known hypersensitivity to doxacurium chloride or any of its components
+Doxacurium chloride should not be used in patients with known hypersensitivity to the drug or any of its components. Caution is advised in patients with [[myasthenia gravis]] or other neuromuscular disorders.
-* Patients with myasthenia gravis or other neuromuscular disorders, as their sensitivity to neuromuscular blockers may be altered
-==Adverse Effects==
+==Related pages==
-While doxacurium chloride is generally well-tolerated, potential adverse effects include:
+* [[Neuromuscular-blocking drug]]
-* Prolonged neuromuscular blockade and respiratory paralysis, particularly in patients with renal or hepatic impairment
+* [[Anesthesia]]
-* Hypersensitivity reactions, although rare
+* [[Acetylcholine]]
+* [[Endotracheal intubation]]
-==Administration==
+[[Category:Neuromuscular blockers]]
-Doxacurium chloride is administered intravenously, and its dosage should be individualized based on the patient's weight, age, and underlying medical conditions. Monitoring of neuromuscular function is recommended to adjust dosage and avoid prolonged neuromuscular blockade.
-==Comparison with Other Neuromuscular Blockers==
-Compared to other neuromuscular-blocking drugs, doxacurium chloride has a slower onset and a longer duration of action. It is most similar to other benzylisoquinolinium compounds, such as [[tubocurarine]] and [[metocurine]], but with fewer cardiovascular and histamine-releasing side effects.
-[[Category:Neuromuscular blocking agents]]
 [[Category:Anesthesia]]
-[[Category:Pharmacology]]
-{{Pharmacology-stub}}
-{{Medicine-stub}}